Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy
Background Androgen-deprivation therapy (ADT) is standard treatment for locally advanced or metastatic prostate cancer (PCa). Many patients develop castration resistance (castration-resistant PCa [CRPC]) after approximately 2-3 yr, with a poor prognosis. The molecular mechanisms underlying CRPC prog...
Үндсэн зохиолчид: | Rajan, P, Sudbery, I, Villasevil, M, Mui, E, Fleming, J, Davis, M, Ahmad, I, Edwards, J, Sansom, O, Sims, D, Ponting, C, Heger, A, McMenemin, R, Pedley, I, Leung, H |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Elsevier
2014
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.
-н: Rajan, P, зэрэг
Хэвлэсэн: (2014) -
Sequencing depth and coverage: key considerations in genomic analyses.
-н: Sims, D, зэрэг
Хэвлэсэн: (2014) -
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
-н: Shtutman Michael, зэрэг
Хэвлэсэн: (2010-04-01) -
The early effects of rapid androgen deprivation on human prostate cancer
-н: Shaw, G, зэрэг
Хэвлэсэн: (2015) -
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
-н: Justin H. Hwang, зэрэг
Хэвлэсэн: (2019-11-01)